Tech Company Financing Transactions
Salient Surgical Funding Round
Salient Surgical closed a $17.9 million Series F venture capital round on 10/29/2008. Backers included Arnerich Massena, Medtronic and Piper Jaffray Ventures.
Transaction Overview
Company Name
Announced On
10/29/2008
Transaction Type
Venture Equity
Amount
$17,900,000
Round
Series F
Investors
Proceeds Purpose
Salient plans to use the net proceeds to fund programs aimed at continuing to expand its sales and marketing organization and accelerating development of new advanced energy products based on its proprietary Transcollation� technology. Salient will also use a portion of the proceeds to fund working capital requirements and amortize term debt.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
180 International Drive
Portsmouth, NH 03801
USA
Portsmouth, NH 03801
USA
Phone
Website
Email Address
Overview
TissueLink Medical provides devices that reduce surgical blood loss. Utilizing TissueLink's saline-enhanced radio-frequency technology allows surgeons to control bleeding and improve patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Army
VP - Finance
Richard Altieri
Browse more venture capital transactions:
Prev: 10/29/2008: Vitae Pharmaceuticals venture capital transaction
Next: 10/29/2008: N30 Pharmaceuticals venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs